Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + propofol vs remifentanil + propofol in severe traumatic brain injury ICU patients
ChiCTR2600120393Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in traumatic brain injury (TBI) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Electroencephalogram (EEG), Pulsatility Index (PI) and 4 more. Started Mar 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2600120393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120393.